Teva China API plant smacked by FDA warning letter, adding to drugmaker's burdens
Teva Pharma Suspends Irvine Production After FDA Probe - Orange County Business Journal
Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter | FDA
Teva months from restarting production at Hungary plant banned by US FDA
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
Celltrion FDA warning causes headache for Teva's biologics ambition
Filling errors, counterfeit packs gain FDA's attention | Packaging World
Amicus Therapeutics: Finally The FDA Inspection Is Done (NASDAQ:FOLD) | Seeking Alpha
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva Recalls U.S.-Made Drugs Following Contamination Fears | 2021-10-04 | SupplyChainBrain
Teva Recalls One Lot Of IDArubicin Hydrochloride Injection
Teva Stops Production At US Plant After FDA Concerns: Report
Site Inspections | Teva api
Cheap Prescription Drugs in U.S. Can Have Hidden Cost - Bloomberg
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva confirms US FDA warning letter for Hangzhou, China API plant
Surprise US FDA inspections: Cause for alarm? | Mint
